Senior insider sale
Chief Commercial Officer at LENZ THERAPEUTICS, INC. — senior position signals high conviction
$1.02M
40K shares
What this filing means
OLSSON SHAWN plans to sell 40K shares of LENZ THERAPEUTICS, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0001950047-25-008982
Officer· Chief Commercial Officer
Since Mar 2024
40K
Shares to sell
$1.02M
Approx. market value
40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/17/2025
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2025 | Exercise of Stock Options Cash | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
40K
Market value
$1.02M
11/17/2025
Total
Units
40K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/17/2025 | 40K | $1.02M | NASDAQ | Planned |
| Total | 40K | $1.02M | ||